CSPC Pharmaceutical Group Limited CSPCY

CSPCY Company Overview

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing, and commercialization of pharmaceutical products. The company operates across the branded pharmaceuticals, bulk vitamin and antibiotic intermediates, and functional food sectors, with a strategic focus on innovative drug development. Its shares are listed on the Hong Kong Stock Exchange, while CHJTF represents its over-the-counter market presence in the United States. CSPC primarily serves the healthcare and pharmaceutical markets in China, while also expanding internationally through licensing agreements, exports, and collaborative partnerships.

The company’s primary revenue drivers are its innovative pharmaceutical products, particularly in oncology, cardiovascular disease, neurology, anti-infectives, and metabolic disorders. CSPC has developed a strong position in China’s pharmaceutical sector through integrated manufacturing capabilities, large-scale research and development investment, and commercialization infrastructure. Founded through the restructuring of state-owned pharmaceutical assets in Hebei Province, the company evolved from a producer of bulk pharmaceutical ingredients into a research-driven pharmaceutical enterprise with a growing innovative drug pipeline and biologics presence.